Vestar acquires HealthGrades for $294m
The New York-based firm has purchased a controlling stake in the healthcare ratings organisation at a price of $8.20 per share.
5 January 2013•1 min read
The New York-based firm has purchased a controlling stake in the healthcare ratings organisation at a price of $8.20 per share.